Med Gen to Ship 20,000 Units of Its Snore Relief Formula to Pacific Rim.

BOCA RATON, Fla. -- Med Gen Inc. (OTCBB:MGEN), manufacturers of the national brands Snorenz(R), snore relief throat spray, Painenz(R), roll on pain relief formula, Good Nights Sleep(R), sleep aid throat spray and the UNDIET(TM) system, announced today that it has received orders to ship the first of 20,000 units of its snore relief formula to its Australian distributor.

Paul Kravitz, Chairman/CEO, told analysts today that it had taken almost eight months of testing and documentation to secure the needed approval of the authorities to allow the entrance of its formula into this part of the world. Aurora Pharmaceuticals Pty Ltd., under its own private label agreement with Med Gen, will market Med Gen's well known Snorenz(R) products in the many countries making up the Pacific Rim. In previous announcements, Med Gen had indicated it was putting its resources behind a fast track entree into various international markets as a way of garnering growth, without the heavy burden of advertising and other marketing costs that it faces domestically.

Equally as important, Mr. Kravitz said, was the investment the company has made of over $100,000 for the re-evaluation and design of its corporate websites and the hiring of a professional internet-marketer. "I am urging all 1200 of our shareholders, here and abroad, to visit these sites (http://www.medgen.com; http://www.snorenz.com; http://www.4goodnightsleep.com; http://www.undietplan.com (in production)) and comment on their effectiveness and marketability. To celebrate the month of May, any proof of your shareholder status by either using our 'comment section' on our web sites or a mail in note or phone call, will get you a 50% discount on any of our products. Everyone should take advantage of this wonderful offer to either restock, or try our Brands for the first time.

"I am confident that our direction is on target for rapid growth. Over the next several months you will see our plan come to life as we experience steady growth from our Direct to Consumer marketing plans as well as our aggressive international plans."

About Med Gen Inc.

Med Gen Inc., in business since 1996, manufactures and markets the world's first liquid spray snoring relief formula, Snorenz(R), for which its founders received a patent in 1998. Since its existence, Med Gen has continued to develop its "Sprays the Way" technology, and in 2003 introduced Good Nights Sleep(R) to the sleep-aid market. Both Snorenz(R) and Good Nights Sleep(R) are nationally advertised and marketed to major chain and drug stores as well as direct sales via TV and the company web sites.

The company has now completed its testing on a radically different approach and delivery system for its weight loss program, UNDIET(TM). IRI, a retail data reporting service, suggests that the combined market for snoring and sleep aides could exceed $500 million and the weight loss market could exceed $60 billion by 2007.

Med Gen Inc. is a full reporting company whose stock trades on the OTCBB under the symbol MGEN.

For further information on Med Gen Inc., please visit http://www.medgen.com

This Press Release contains or incorporates by reference "forward looking" statements including certain information with respect to plans and strategies of Med Gen Inc. For this purpose, any statements contained herein or incorporated herein by references that are not statements of historical fact may be deemed forward looking statements. Without limiting the foregoing, the words "believes", "suggests", "anticipates", "plans", "expects", and similar expressions are intended to identify forward looking statements. There are a number of events or actual results of Med Gen operations that could differ materially from those indicated by such forward looking statements.

Med Gen, Inc. is a publicly traded company on the OTCBB exchange "MGEN".